SEARCH RESULTS FOR:

Mining
Canada

Mark Bristow

PRESIDENT & CEO, BARRICK GOLD
Mark Bristow speaks to GBR of how Barrick Gold’s navigated an unusual year.
Mining
Peru

Jay Chmelauskas

PRESIDENT & CEO, CAMINO CORPORATION
Camino Corp. explains its restart of the Los Chapitos copper project.
Mining
Cote d’Ivoire
Burkina Faso
MACIG

Sébastien de Montessus

CEO, ENDEAVOUR MINING CORPORATION
Endeavour Mining has continued all operations across its West African assets, amassing an impressive portfolio.
Mining
Nigeria
MACIG

David Turvey

MANAGING DIRECTOR, KOGI IRON LIMITED
Kogi Iron is building Nigeria’s first steel producing facility at its Agbaja iron ore deposit.
Mexico
Petrochemicals & Chemicals

Martin Sack & Francisco Galvez

REGIONAL HEAD – AMERICAS & MANAGING DIRECTOR – MEXICO, LESCHACO
Leschaco in Mexico explains how the logistics sector has weathered the COVID storm.
Mining
Canada

Denis S. Frawley

PARTNER, ORMSTON LIST FRAWLEY LLP
Ormston List Frawley LLP comments on the current environment for M&A in the mining industry.
Petrochemicals & Chemicals
Singapore

Dr. Tim Philippi

EXECUTIVE DIRECTOR, SINGAPOREAN-GERMAN CHAMBER OF INDUSTRY AND COMMERCE (SGC)
The Singaporean-German Chamber of Industry and Commerce speaks to GBR of how the two leading chemical hubs can cooperate.
Mining
Colombia

Eduardo Cossio Chirinos

CEO, INCIMMET
INCIMMET explains why it is focusing on growth in the Colombian mining industry.
Mexico
Petrochemicals & Chemicals

Abraham Klip Moshinsky

DIRECTOR GENERAL, UNIGEL MEXICO
Unigel has enjoyed a successful year in Mexico.
Mining
Canada

Hon. Greg Rickford

MINISTER OF ENERGY, MINES, NORTHERN DEVELOPMENT AND INDIGENOUS AFFAIRS, GOVERNMENT OF ONTARIO
Ontario’s Minister of Mines explains what his ministry did wrong during 2020 and also what they have set right to ensure mines lead Ontario’s recovery.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL